Skip to content

Clinical trials

Central Nervous System Diseases trials in Finland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Central Nervous System Diseases Country / region: Finland Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20161
20183
20192
20201
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated3
Active, not recruiting1
Enrolling by invitation1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Neuroscience Trials Australia2
AC Immune SA1
Eli Lilly and Company1
Herantis Pharma Plc.1
Hoffmann-La Roche1
Novartis Pharmaceuticals1
Orion Corporation, Orion Pharma1
Remedy Pharmaceuticals, Inc.1
Renishaw1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Central Nervous System Diseases13
Brain Diseases10
Nervous System Diseases8
Alzheimer Disease5
Dementia5
Cardiovascular Diseases4
Neurodegenerative Diseases4
Stroke4
Cerebrovascular Disorders3
Mental Disorders3

Trials

Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.